Skip to Main Content

Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

Conditions

Diseases of the Nervous System | Men's Health | Women's Health | Headaches

Phase III

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH).

  • Trial with
    Lundbeck Inc
  • Start Date
    03/09/2022
  • End Date
    01/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/11/2022
  • Study HIC
    #2000031744